Bala Mohan — SEC Form 4 filings
SEC reporting owner CIK 1991787. 7 Form 4 filings on record with FilingPulse; latest filed 2026-01-06.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-01-17 to 2026-01-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 6 filings — 28,271 shares, $46,382 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 28.
- Largest priced transaction: sale of 8,089 shares @ $2.00 ($16,178) in Mersana Therapeutics, Inc., filed 2024-10-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Mersana Therapeutics, Inc. (MRSN) | SVP, Chief Development | 7 | — | 7 legs · 28,271 sh · $46,382 | 28 |
Form 4 filings — Bala Mohan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-06 | 4 | Mersana Therapeutics, Inc. (MRSN) | Code (U): 2,927 · Disposition to issuer (D): 3,515 (derivative) · Disposition to issuer (D): 7,734 (derivative) · Disposition to issuer (D): 1,853 (derivative) · Disposition to issuer (D): 2,646 (derivative) · Disposition to issuer (D): 1,053 (derivative) · +6 more | EDGAR |
| 2025-10-28 | 4 | Mersana Therapeutics, Inc. (MRSN) | Option exercise (M): 250 @ $0 · Sale (S): 77 @ $9.90 · Option exercise (M): 250 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | Mersana Therapeutics, Inc. (MRSN) | Option exercise (M): 14,583 @ $0 · Sale (S): 5,939 @ $0.58 · Option exercise (M): 14,583 (derivative) @ $0 · Grant/award (A): 281,250 (derivative) @ $0 · Grant/award (A): 62,500 (derivative) @ $0 | EDGAR |
| 2025-01-15 | 4 | Mersana Therapeutics, Inc. (MRSN) | Option exercise (M): 8,750 @ $0 · Sale (S): 3,253 @ $0.66 · Option exercise (M): 8,750 (derivative) @ $0 | EDGAR |
| 2024-10-29 | 4 | Mersana Therapeutics, Inc. (MRSN) | Option exercise (M): 6,250 @ $0 · Sale (S): 1,884 @ $1.90 · Option exercise (M): 6,250 (derivative) @ $0 | EDGAR |
| 2024-10-07 | 4 | Mersana Therapeutics, Inc. (MRSN) | Option exercise (M): 50,000 @ $0 · Sale (S): 8,089 @ $2 · Sale (S): 5,598 @ $1.96 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2024-01-17 | 4 | Mersana Therapeutics, Inc. (MRSN) | Option exercise (M): 8,750 @ $0 · Sale (S): 3,431 @ $2.71 · Option exercise (M): 8,750 (derivative) @ $0 · Grant/award (A): 262,500 (derivative) @ $0 · Grant/award (A): 58,333 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1991787 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →